Medical and Scientific Advisory Board
Our Scientific Advisory Board and Medical Advisory Board members have devoted their time and medical expertise to improving the lives of those afflicted with KCNQ2-elated disorders
MEDICAL and SCIENTIFIC ADVISORY BOARD
KCNQ2-developmental and epileptic encephalopathy are a severe epilepsy and developmental disorder beginning in the newborn period. While epilepsy may settle in infancy, the child’s development may often be very impaired. Other co-morbidities can occur such as autism spectrum disorder. Research and collaboration are the way forward to improve the lives of children and their families living with KCNQ2-related encephalopathies.
- Professor Ingrid Scheffer
Alfred George, Jr., MD
Board Chair
Northwestern University Feinberg School of Medicine
Dennis Dlugos, MD, MSCE
Children's Hospital of Philadelphia
Orrin Devinsky, MD
New York Langone Health
Mark Fitzgerald, MD, PhD
Children's Hospital of Philadelphia
Natasha Ludwig, PhD
Kennedy Krieger Institute
Kristen Park, MD
Children's Hospital of Colorado
Annapurna Poduri, MD, MHP
Boston Children's Hospital
Tristan Sands, MD, PhD
Columbia Univeristy
Ingrid Scheffer, MD, PhD
University of Melbourne
Maurizio Taglialatela, MD, PhD
University of Naples Federico II
Anastasios Tzingounis, PhD
Children's Hospital of Philadelphia
Sarah Weckhuysen, MD, PhD
University of Antwerp